Andre Birgy (André Birgy)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Blood Brain Barrier

Dna Methylation

Top Venues

Antimicrobial agents and chemotherapy

Journal of clinical microbiology

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Andre Birgy, Christina Nnabuife, Timothy G Palzkill
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrobial agents and chemotherapy (2024)
Andre Birgy, Christina Nnabuife, Timothy G Palzkill
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrobial agents and chemotherapy 68 (3) (2024)
Andre Birgy, Christina Nnabuife, Timothy G Palzkill
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrobial agents and chemotherapy 68 (3) (2024)
Andre Birgy, Christina Nnabuife, Timothy G Palzkill
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrobial agents and chemotherapy 68 (3) (2024)
Andre Birgy, Christina Nnabuife, Timothy G Palzkill
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrobial agents and chemotherapy 68 (3) (2024)
Andre Birgy, Christina Nnabuife, Timothy G Palzkill
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrobial agents and chemotherapy 68 (3) (2024)
Andre Birgy, Christina Nnabuife, Timothy G Palzkill
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate. Antimicrobial agents and chemotherapy 68 (3) (2024)
Claire Amaris Hobson, Gautier Pierrat, Olivier Tenaillon, Stéphane Bonacorsi, Beatrice Bercot, Ella Jaouen, Hervé Jacquier, Andre Birgy
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview. Antimicrobial agents and chemotherapy 66 (9) (2022)
Claire Amaris Hobson, Stéphane Bonacorsi, André Baruchel, Olivier Tenaillon, Andre Birgy
The interplay between anticancer challenges and the microbial communities from the gut. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (5) (2022)
Etienne Bizot, Aurélie Cointe, Philippe Bidet, Patricia Mariani-Kurkdjian, Claire Amaris Hobson, Céline Courroux, Sandrine Liguori, Antoine Bridier-Nahmias, Mélanie Magnan, Manel Merimèche, François Caméléna, Béatrice Berçot, François-Xavier Weill, Sophie Lefèvre, Stéphane Bonacorsi, Andre Birgy
Azithromycin resistance in Shiga-toxin Producing Escherichia coli in France between 2004 and 2020 and detection of mef(C)-mph(G) genes. Antimicrobial agents and chemotherapy (2021)
Claire Amaris Hobson, Stéphane Bonacorsi, Hervé Jacquier, Alaksh Choudhury, Mélanie Magnan, Aurélie Cointe, Beatrice Bercot, Olivier Tenaillon, Andre Birgy
KPC Beta-Lactamases Are Permissive to Insertions and Deletions Conferring Substrate Spectrum Modifications and Resistance to Ceftazidime-Avibactam. Antimicrobial agents and chemotherapy 64 (12) (2020)
Morgane Petit, François Caméléna, Aurélie Cointe, Thibaut Poncin, Manel Merimèche, Stéphane Bonacorsi, Andre Birgy, Beatrice Bercot
Rapid Detection and Characterization of Carbapenemases in Enterobacterales with a New Modified Carbapenem Inactivation Method, mCIMplus. Journal of clinical microbiology 58 (11) (2020)